FTC sues major pharmacy benefit managers over insulin charges The agency brought motion versus Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing price of life-saving insulin prescription drugs. Now that some electronic overall health startups funded throughout the peak of your https://labelthefigurewiththeitem50594.azzablog.com/30774658/everything-about-healthcare-news